EMA Lays Out Plans For Routine Use Of Real-World Evidence

EU Draft Artificial Intelligence Guideline Slated For November 2022

A panel of regulators overseeing the implementation of several big data projects within the EU medicines network has given details of real-world evidence integration pilots to be undertaken next year by various European Medicines Agency scientific committees.

Futuristic programming code and big data connections and network patterns. 3D illustration.
Regulators will increasingly use insights derived from big data to assess the benefit-risk of medicines • Source: Alamy

More from Real-World Evidence

More from Clinical Trials